Saliba, Jessica L.; Deleuze-Masquefa, Carine; Iskandarani, Ahmad N.; El-Eit, Rabab M.; Hmadi, Raed A.; Mahon, François Xavier; Bazarbachi, Ali Abdul Hamid; Bonnet, Pierre Antoine; Nasr, Rihab R.
(Lippincott Williams and Wilkins, 2014)
Imatinib, the first-generation tyrosine kinase inhibitor, revolutionized the therapeutic management of chronic myeloid leukemia (CML) and is highly effective in inducing remissions and prolonging the survival of CML patients. ...